You are here

Aminosterols as Anti-angiogenic Therapeutics for AMD

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43EY015971-01
Agency Tracking Number: EY015971
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
ATTN: CHRIS SCHNITTKER 5110 CAMPUS DRIVE
PLYMOUTH MEETING, PA 19462
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 HSIAOLING Hung
 (610) 941-5656
 HHUNG@GENAERA.COM
Business Contact
Phone: (610) 941-5231
Research Institution
N/A
Abstract

Age-related macular degeneration (AMD) is a public health problem resulting in the loss of independence in a significant number of the elderly population. The most severe form of AMD, wet AMD, is caused by the formation of new blood vessels in the choroid

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government